Objective. To investigate crosslinks between catabolic and anabolic pathways in articular cartilage by examining the synthesis and distribution pattern of microsomal prostaglandin E synthase 1 (mPGES-1) in healthy and osteoarthritic (OA) cartilage and analyzing its functional relationship to hypoxia-inducible factor 1␣ (HIF-1␣) in primary articular chondrocytes.Methods. Normal cartilage and OA cartilage were subjected to immunohistochemical staining for mPGES-1 and HIF-1␣. Isolated chondrocytes were cultivated under 21% or 1% O 2 . Microarray analysis and quantitative reverse transcriptase-polymerase chain reaction were used to detect genes differentially expressed in chondrocytes cultured under normoxic compared with hypoxic conditions. Immunoblotting was conducted to evaluate intracellular protein levels of mPGES and nuclear accumulation of HIF-1␣ under different oxygen tension levels and with different stimulatory or inhibitory chemical agents.Results. We found enhanced levels of expression of the mPGES-1 gene and an increased number of OA chondrocytes showing staining for mPGES-1 in OA cartilage. Microarray analysis demonstrated that mPGES-1 was among the genes that were up-regulated to the greatest degree in primary chondrocytes exposed to 1% O 2 . In vitro, hypoxia led to an enhanced synthesis of mPGES-1, coinciding with a nuclear accumulation of the transcription factor HIF-1␣. In chondrocyte culture, stimulation with dimethyloxaloylglycine promoted the expression of mPGES-1, phosphoglycerate kinase 1, and cyclooxygenase 2 (COX-2) by stabilizing HIF-1␣ protein levels. A reduction of mPGES-1 synthesis was detected after treatment with 2-methoxyestradiol, correlating with lower HIF-1␣ activity. In contrast, synthesis of mPGES-1 was not influenced by treatment with the specific COX-2 inhibitor NS398.Conclusion. These findings suggest that the transcription factor HIF-1␣ is involved in the up-regulation of mPGES-1 and may therefore play an important role in the metabolism of OA cartilage.The regulation of the metabolism of articular cartilage involves a complex network of a multitude of signaling pathways. In osteoarthritis (OA), the usually well-regulated maintenance between extracellular matrix synthesis and degradation is greatly disturbed. Inflammatory cytokines promote catabolism by inducing expression of matrix-degrading enzymes, which lead to the breakdown of the collagen network and the release of cartilage proteoglycans (1). The biologic effects of interleukin-1 (IL-1), one of the key agents in the pathophysiology of OA, are mediated by signaling pathways involving NF-B, JNK, p38, or ERK, by nitric oxide, and by cytokines as well as by prostaglandins (2). Prostaglandin E 2 (PGE 2 ), the most abundant prostaglandin in the skeletal system (3), induces a number of matrix-degrading enzymes, thus stimulating the cataboSupported by the Interdisciplinary Center of Clinical Research Erlangen (Project C2) and the DFG (PF 383/4-1).